Early Phase Cancer Immunotherapy

This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Patel, Sandip Pravin (Editor, http://id.loc.gov/vocabulary/relators/edt), Kurzrock, Razelle (Editor, http://id.loc.gov/vocabulary/relators/edt)
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2018.
Edition:1st ed. 2018.
Series:Current Cancer Research,
Subjects:
Online Access:Full Text via HEAL-Link
Table of Contents:
  • Chapter 1 Primer on Cancer Immunotherapy and the Targeting of Native Proteins
  • Chapter 2 Pharmacokinetics and Pharmacodynamics of Immunotherapy
  • Chapter 3 Immunotherapeutic Biomarkers and Selection Strategies
  • Chapter 4 Radiographic Evaluation of Immunotherapy
  • Chapter 5 Cellular Therapy
  • Chapter 6 Combinatorial Checkpoint Blockade Immunotherapy and Radiation
  • Chapter 7 Early Phase Cancer Immunotherapy
  • Chapter 8 Immune Checkpoint Combinations with Inflammatory Pathway Modulators
  • Chapter 9 Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials
  • Chapter 10 Thoracic Immunotherapy.